Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9346783
Method and apparatus for producing oxidized compound
granted -
US 9326946
Laminated tablet and manufacturing method therefor
granted -
US 9320714
Tablet
granted -
US 9321757
Heterocyclic compound
granted -
US 9315458
Nitrogen-containing heterocyclic compound
granted -
US 9303045
5-HT3 receptor antagonists
granted -
US 9296746
Heterocyclic compound
granted -
US 9290456
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 9278938
Production method of imidazole derivatives
granted -
US 9278931
Cyclopropaneamine compound
granted -
US 9265730
Stable solid preparations
granted -
US 9260500
Peptide and use thereof
granted -
US 9241910
Orally-disintegrating solid preparation
granted -
US 9238639
Aromatic ring compound
granted -
US 9226921
Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
granted -
US 9221836
Heterocyclic compound and use thereof
granted -
US 9212149
Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors
granted -
US 9212147
Dihydroxy aromatic heterocyclic compound
granted -
US 9200051
Peptide compound
granted -
US 9199963
Heterocyclic compound
granted -
US 9193709
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
granted -
US 9187497
Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)
granted -
US 9187453
Heterocyclic compound
granted -
US 9186411
Pharmaceutical composition
granted